Hi, help us enhance your experience
Hi, help us enhance your experience
Hi, help us enhance your experience
4181 Views
eMediNexus 12 February 2018
which is under consideration and is pending approval. HCFI can give its suggestions on the draft policy as one of the policy initiative is one drug one company one and encouraging medical practitioners to prescribe generic name drugs instead of brand names.
The key objectives of the Policy is to:
{{Article_Title}}
{{Article_Author}}
{{Article_Title}}
{{Article_Author}}